VERACYTE, INC. Quarterly Return On Equity in % from Q4 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Veracyte, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q2 2024.
  • Veracyte, Inc. Return On Equity for the quarter ending June 30, 2024 was -4.97 %, a 83.4% decline year-over-year.
  • Veracyte, Inc. annual Return On Equity for 2023 was -6.98 %, a 104% decline from 2022.
  • Veracyte, Inc. annual Return On Equity for 2022 was -3.42 %, a 53% increase from 2021.
  • Veracyte, Inc. annual Return On Equity for 2021 was -7.28 %, a 32.1% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -4.97 -2.26 -83.4% Apr 1, 2024 Jun 30, 2024
Q1 2024 -6.34 -3.51 -124% Jan 1, 2024 Mar 31, 2024
Q4 2023 -6.98 -3.56 -104% Oct 1, 2023 Dec 31, 2023
Q3 2023 -4.65 -0.63 -15.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -2.71 +1.76 +39.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -2.83 +1.69 +37.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 -3.42 +3.86 +53% Oct 1, 2022 Dec 31, 2022
Q3 2022 -4.03 +4.39 +52.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -4.47 +4.57 +50.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -4.52 +8.21 +64.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -7.28 +3.45 +32.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -8.42 +3.86 +31.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -9.04 +4.3 +32.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -12.7 -3.05 -31.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -10.7 -4.26 -65.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -12.3 Jul 1, 2020 Sep 30, 2020
Q2 2020 -13.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 -9.68 Jan 1, 2020 Mar 31, 2020
Q4 2019 -6.47 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.